On Mar. 13, 2019, Eric Lander, Franooise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg and specialists from seven…
On Mar. 5, 2019, Emma, the 90-ton cyclotron which is the centerpiece of the new proton therapy initiative…
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
On Jan. 18, 2019 Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
On Jan. 18, 2019, Masonic Cancer Center researcher Branden Moriarity, PhD, received a U24 Grant with Recombinetics. The…
On Dec. 12, 2018, the Allen Institute announced the launch of the Allen Institute for Immunology, a new…
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
On Nov. 30, 2018, Sean Norman, associate professor of environmental health sciences and director of the Molecular Microbial…
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
On Nov. 2, 2018, AcelRx pharmaceutical’s DSUVIA was approved by U.S. Food and Drug Administration (FDA). DSUVIA is…
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
On Oct. 24, 2018, the U.S. Food and Drug Administration (FDA) announced it had granted approval of Xofluza…
On Oct. 22, 2018, the National Cancer Institute awarded a $10.7 million five year grant to Abramson Cancer…
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
On Oct. 2, 2018, Martin Health System and Cleveland Clinic signed a definitive agreement resulting in Martin Health…
On Sept. 27, 2018, St.ﾠJude Children’s Hospital and the World Health Organization announced a five-year collaboration to transform…
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
On Sept. 13, 2018, the Genome 10K (G10K) announced the launch of the international Vertebrate Genomes Project (VGP),…
On Sept. 11, 2018, the National Science Foundation (NSF) awarded a three year $1 million grant to scientists…
On Sept. 7, 2018, Oregon Health & Science University (OHSU) announced the official completion of the Knight Cancer…
On Aug. 24, 2018, Emory Universityﾒs Alzheimer’s Disease Research Center was renamed the Goizueta Alzheimer’s Disease Research Center,…